SCHEMBL5211183

SCHEMBL5211183

Cc1oc(-c2ccccc2C(F)(F)F)nc1CSc1ccc(S(=O)(=O)N2CCC[C@H]2OC(=O)O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
SMN1; SMN2 Q16637 6/20 0.38
MAPT P10636 4/20 0.38
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C19 P33261 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP2C9 P11712 2/20 0.38
TP53 P04637 3/20 0.37
CYP2D6 P10635 1/20 0.37
LMNA P02545 4/20 0.37
TSHR P16473 2/20 0.37
POLB P06746 1/20 0.36
PTBP1 P26599 1/20 0.36
BRD4 O60885 1/20 0.35
HCRTR1 O43613 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5211174 0.90 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2MAPTCYP1A2CYP3A4
SCHEMBL5210830 0.88 MAPT (0.43) MAPTTP53POLB
SCHEMBL5206559 0.87 MAPT (0.46) ALDH1A1MAPTMEN1KMT2ATP53
SCHEMBL5213499 0.86 MAPT (0.42) ALDH1A1MAPTMEN1KMT2ATP53
SCHEMBL5207399 0.84 PPARA (0.42) ALDH1A1SMN1; SMN2MAPTTP53LMNA
SCHEMBL5210969 0.80 HRH3 (0.44)
SCHEMBL2523387 0.77 MAPT (0.46) ALDH1A1MAPTTP53POLBKDM4E
SCHEMBL2523386 0.77 MAPT (0.46) ALDH1A1MAPTTP53POLBKDM4E
SCHEMBL2523123 0.76 MAPT (0.49) ALDH1A1MAPTMEN1KMT2ATP53
SCHEMBL2523125 0.76 MAPT (0.49) ALDH1A1MAPTMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448523-B1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE NOVARTIS AG (CH) 2007-08-22 EP claimed